NIIHARA YUTAKA (Chairman and CEO) purchased 0.2% of their position (27.50K shares) of EMMAUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $12.0K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/3/2022ACC: 0001209191-22-055471
DirectorOfficer10% Owner· Chairman and CEO
Since Jul 2019
+27.50K
Net shares
Net buyer
$12.0K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
27.50K acquired
Non-Derivative Transactions3
Common stock, $0.001 par value
Direct
Shares
+7.50K
Price / share
$0.45
Trade value
$3.38K
% of position
0.1%
10/31/2022
11.96M→11.97M
Common stock, $0.001 par value
Direct
Shares
+5K
Price / share
$0.43
Trade value
$2.15K
% of position
0.0%
11/1/2022
11.97M→11.97M
Common stock, $0.001 par value
Direct
Shares
+15K
Price / share
$0.43
Trade value
$6.45K
% of position
0.1%
11/2/2022
11.97M→11.99M
Total
Net shares
+27.50K
Net value
$11.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.001 par value Direct | 10/31/2022 | P · Purchase | +7.50K | $0.45 | $3.38K | 0.1% | 11.96M | 11.97M |
| Common stock, $0.001 par value Direct | 11/1/2022 | P · Purchase | +5K | $0.43 | $2.15K | 0.0% | 11.97M | 11.97M |
| Common stock, $0.001 par value Direct | 11/2/2022 | P · Purchase | +15K | $0.43 | $6.45K | 0.1% | 11.97M | 11.99M |
| Total | +27.50K | $11.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common stock, $0.001 par value
IndirectShares owned92.79K
Common stock, $0.001 par value
IndirectShares owned63K
Total
155.79K indirect155.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.001 par value | 92.79K | Indirect |
| Common stock, $0.001 par value | 63K | Indirect |
| Total | 155.79K | 155.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported